Therapies for metastatic<unk>  include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib.
Acral lentiginous melanoma
Lentigo maligna melanoma
Superficial spreading melanoma
Polypoid melanoma
Nodular melanoma
Melanocytic nevus
Animal-type melanoma
Pseudomelanoma